Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

H Lundbeck A/S

HLUN A.CO ✓ COMPLIANT ☆ Track — members

Nasdaq Copenhagen · Healthcare · Pharmaceuticals ·

Denmark Mid Cap Analyst: N/A

Last Close

$5.57

▲ +0.56%

Market Cap $6.33B · Vol 121.71K

Key Metrics

P/E Ratio

9.67

FWD: 6.12

Market Cap

$6.33B

Mid Cap

Div Yield

3.19%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

44.44

Momentum

Beta

0.77

vs Market

52W High

$6.18

12.64% below

52W Low

$4.86

15.03% above

Volume

121.71K

Avg 64.49K

P/B

1.44

Price-to-book

ROE

14.17%

Return on equity

Free Float

19.89%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, H Lundbeck A/S (HLUN A.CO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HLUN A.CO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.27%

+0.42%

+0.00%

+1.41%

YTD

-0.55%

+10.09%

+18.85%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$3.87B
Net Income	$501.99M
Revenue Growth (YoY)	+14.27%
Gross Margin	82.45%
Operating Margin	27.04%
Net Profit Margin	12.96%
ROE	14.17%
ROA · ROIC	8.23% · 9.09%

P/E Ratio	9.67
Forward P/E (FY1)	6.12
PEG Ratio	7.53
P/S	1.46
P/B	1.44
P/FCF	7.38
EPS Growth	N/A
Outstanding Shares	995.74M

Technical Indicators

50-Day SMA	$5.62
200-Day SMA	$5.51
RSI (14)	44.44
Beta	0.77
52-Week High	$6.18
52-Week Low	$4.86

Volume Today	121.71K
Avg Daily Volume (30D)	64.49K
Relative Volume	1.89x
Volatility (10D)	11.51
Volatility (30D)	10.25
Free Float	19.89%

Analyst Consensus

N/A

Current Price $5.57

Mean Target N/A

52W Low$4.86 52W High$6.18

Current

Target

$4.86 $6.18

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq Copenhagen

FIGIBBG017ZL9428

ISINDK0061804697

CountryDenmark

Sub-IndustryPharmaceuticals Wholesale

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MCK McKesson Corp +1.44% CAH Cardinal Health, Inc +1.70% SIG.AX Sigma Healthcare Ltd +0.00% 000963.SZ Huadong Medicine Co Ltd +0.54% GALE.S Galenica AG +0.31%

Company Profile

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.